Åsa Alsiö
-
PCR detection of respiratory pathogens in asymptomatic and symptomatic
adults.
Nicklas Sundell, Lars-Magnus Andersson, Robin Brittain-Long, Pär-Daniel Sundvall, Åsa Alsiö, Magnus Lindh, Lars Gustavsson, Johan Westin
Journal of clinical microbiology - 2019-01-01 -
Short interferon and ribavirin treatment for HCV genotype 2 or 3 infection: NORDynamIC trial and real-life
experience
Jesper Waldenström, M. Farkkila, Karolina Rembeck, Gunnar Norkrans, N. Langeland, K. Morch, C. Pedersen, M. Rauning Buhl, U. Nieminen, H. Nuutinen, Åsa Alsiö, L. Holmstrom, R. Jungnelius, K. Lund, A. Rubensson, E. Torell, Johan Westin, Martin Lagging
Scandinavian Journal of Gastroenterology - 2016-01-01 -
Early quantification of HCV core antigen may help to determine the duration of therapy for chronic genotype 2 or 3 HCV
infection
Åsa Alsiö, A. Jannesson, N. Langeland, C. Pedersen, M. Farkkila, M. R. Buhl, K. Morch, Johan Westin, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
European Journal of Clinical Microbiology & Infectious Diseases - 2012-01-01 -
Impact of IL28B-related single nucleotide polymorphisms on liver histopathology in chronic hepatitis C genotype 2 and
3.
Karolina Rembeck, Åsa Alsiö, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Johan Westin, Magnus Lindh, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
PloS one - 2012-01-01 -
Impact of Obesity on the Bioavailability of Peginterferon-α2a and Ribavirin and Treatment Outcome for Chronic Hepatitis C Genotype 2 or
3.
Åsa Alsiö, Karolina Rembeck, Galia Askarieh, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Bart L Haagmans, Salmir Nasic, Johan Westin, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
PloS one - 2012-01-01 -
Look-back screening for the identification of transfusion-induced hepatitis C virus infection in
Sweden
Magdalena Ydreborg, Ann Söderström, Agneta Håkanson, Åsa Alsiö, B Arnholm, P Malmstrom, Kristoffer Hellstrand, Johan Westin, Martin Lagging
Scandinavian Journal of Infectious Diseases - 2011-01-01 -
Is HCV RNA analysis at day 7 cost-effective in deciding the duration of therapy in chronic HCV genotype 2/3
infection?
Martin Lagging, Åsa Alsiö, Kristoffer Hellstrand, Gunnar Norkrans
Journal of hepatology - 2011-01-01 -
On the outcome of antiviral therapy for hepatitis C virus genotype 2 or 3
infection
Åsa Alsiö
- 2011-01-01 -
Ribavirin plasma concentration is a predictor of sustained virological response in patients treated for chronic hepatitis C virus genotype 2/3
infection.
C Pedersen, Åsa Alsiö, Martin Lagging, N Langeland, M Färkkilä, M Rauning Buhl, K Mørch, Johan Westin, P Sangfelt, Gunnar Norkrans, P Brehm Christensen
Journal of viral hepatitis - 2011-01-01 -
Systemic and intrahepatic interferon-gamma-inducible protein 10 kDa predicts the first-phase decline in hepatitis C virus RNA and overall viral response to therapy in chronic hepatitis
C.
Galia Askarieh, Åsa Alsiö, Paolo Pugnale, Francesco Negro, Carlo Ferrari, Avidan U Neumann, Jean-Michel Pawlotsky, Solko W Schalm, Stefan Zeuzem, Gunnar Norkrans, Johan Westin, Jonas Söderholm, Kristoffer Hellstrand, Martin Lagging
Hepatology - 2010-01-01 -
Nonresponder patients with hepatitis C virus genotype 2/3 infection: a question of low systemic interferon
concentrations?
Åsa Alsiö, Peer Brehm Christensen, Martti Färkkilä, Nina Langeland, Mads Rauning Buhl, Court Pedersen, Kristine Mørch, Bart L Haagmans, Johan Westin, Kristoffer Hellstrand, Gunnar Norkrans, Martin Lagging
Clinical infectious diseases - 2010-01-01 -
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus
infection.
Johan Westin, Magdalena Ydreborg, Sara Islam, Åsa Alsiö, Amar P Dhillon, Jean-Michel Pawlotsky, Stefan Zeuzem, Solko W Schalm, Carlo Ferrari, Avidan U Neumann, Kristoffer Hellstrand, Martin Lagging
Scandinavian journal of gastroenterology - 2008-01-01 -
Randomized comparison of 12 or 24 weeks of peginterferon alpha-2a and ribavirin in chronic hepatitis C virus genotype 2/3
infection.
Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Amar P Dhillon, Åsa Alsiö, Kristoffer Hellstrand, Johan Westin, Gunnar Norkrans
Hepatology (Baltimore, Md.) - 2008-01-01 -
Weight-adjusted dosing of ribavirin and importance of hepatitis C virus RNA below 1000 IU/mL by day 7 in short-term peginterferon therapy for chronic genotype 2/3 hepatitis C virus
infection.
Martin Lagging, Nina Langeland, Court Pedersen, Martti Färkkilä, Mads Rauning Buhl, Kristine Mørch, Amar P Dhillon, Åsa Alsiö, Kristoffer Hellstrand, Johan Westin, Peer Christensen, Peter Leutscher, Gunnar Norkrans
Hepatology (Baltimore, Md.) - 2008-01-01 -
Cerebrovascular complications in patients with left-sided infective endocarditis are common: a prospective study using magnetic resonance imaging and neurochemical brain damage
markers.
Ulrika Snygg-Martin, Lars E Gustafsson, Lars Rosengren, Åsa Alsiö, Per Ackerholm, Rune Andersson, Lars Olaison
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 2008-01-01 -
Impact of disease severity on outcome of antiviral therapy in treatment-naive patients with chronic hepatitis
C
Johan Westin, Kristoffer Hellstrand, Åsa Alsiö, Magdalena Ydreborg, Carlo Ferrari, Avidan U Neumann, Jean-Michel Pawlotsky, Solko W Schalm, Stefan Zeuzem, Elke Verhey-Hart, Martin Lagging
Hepatology - 2007-01-01